Khondrion
PrivateLast Round
VC Round
May 6, 2025
Total Funding Raised
$3.82M
Company Overview
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Khondrion Comparables
Compare Khondrion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OMEICOS Therapeutics | 86% | |
| Morningside | 84% | |
| Tisento Therapeutics | 83% | |
Khondrion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 6, 2025 | ||||
| VC Round | Nov 21, 2024 | ||||
| Grant | Jul 31, 2018 | ||||
| Grant | Sep 12, 2016 |
Khondrion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Innovation Council Fund | Grant |
| Ride4Kids | VC Round |
| The Total Innovation Management Foundation | VC Round |
| United Mitochondrial Disease Foundation | VC Round |
| Stichting Join4Energy | VC Round |
| European Regional Development Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Grew 33% QoQ from 9 to 12 employees.
- Dec 24, 2025
Grew 100% QoQ from 6 to 12 employees.
Khondrion Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Khondrion's valuation, stock price, and market status.